upadacitinib
abbvie
['upadacitinib', 'ibd']
#upadacitinib 30 mg more efficacious in maintenance than 15 mg over 1 year in #uc. both maintain remission well with early relapse observed in pbo. feagan presented data at #acg2022 #ibd 
The Jill Roberts Center for IBD at Weill Cornell Medicine and NewYork-Presbyterian